SCHEMBL28068013

SCHEMBL28068013

[c]1c(OCc2ccccc2)ccc2cccnc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.50
LTA4H P09960 1/20 0.44
MAPK14 Q16539 1/20 0.44
ALOX5 P09917 1/20 0.44
EGLN1 Q9GZT9 1/20 0.40
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SGMS2 Q8NHU3 1/20 0.37
PDE5A O76074 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
PRMT5 O14744 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
STAT3 P40763 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22116639 0.79 KDM4E (0.36) CYP3A4KDM4EALDH1A1PDE5ANPC1
SCHEMBL733300 0.77 ALOX5 (0.49) CYP3A4ALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL20578956 0.76 LMNA (0.34) CYP3A4KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL747234 0.75 PDGFRB (0.41) CYP3A4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2921924 0.74 LTA4H (0.46) CYP3A4LTA4HMAPK14KDM4EALDH1A1
SCHEMBL3058689 0.72 MAPT (0.50) ALOX5RAB9ASMN1; SMN2L3MBTL1MAPT
SCHEMBL22116434 0.71 MEN1 (0.38) CYP3A4KDM4EALDH1A1SMN1; SMN2MEN1
SCHEMBL1654659 0.69 CYP3A4 (0.54) CYP3A4LTA4HMAPK14ALOX5EGLN1
SCHEMBL224231 0.68 LTA4H (0.46) CYP3A4LTA4HMAPK14ALOX5KDM4E
SCHEMBL10324103 0.67 MAPT (0.46) LTA4HMAPK14NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105636953-B 1,4 dibasic pyridyl derivatives and its purposes for treating the illness related to SMN shortages 诺华股份有限公司 2018-01-02 CN disclosed
CN-105636953-A 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions NOVARTIS AG 2016-06-01 CN disclosed